Contents of this document
- Increase in operating income from functional materials+¥2.5 billion (year on year)
- Increase in operating income from agricultural chemicals+¥200 million (year on year)
- Increase in operating income from chemicals+¥200 million (year on year)
- Increase in operating income from healthcare+¥200 million (year on year)
- Increase in fixed costs and other expenses for functional materials¥1.6 billion (including ¥1.2 billion for semiconductor materials)
- Lower-than-expected fixed costs and other expenses for functional materials¥1 billion (versus forecast; profit-increasing factor)
- Assumed full-year exchange rate150 Yen/Dollar
- Semiconductor materials market growth rate (2024–2030 CAGR)10 %
- Our semiconductor materials revenue growth rate (2024–2030 CAGR)+20%~
- Partial revision of executive compensation structureDetailsChanged to 50% base compensation, 30% performance-linked compensation and 20% stock-based compensation, with stock-based compensation linked to ROE and TSRTimingApril 2026
- Zero N2O emissions from nitric acid plantsPlanned investment¥830 millionVariable costs¥70 million per year
- EBITDA¥255 hundred millionYear on year against the same period last year+¥4.1 billion
- EPS¥125.74 per shareYear on year against the same period last year+¥23.54
- Operating margin27.8 %Year on year against the same period last year+1.9 percentage points
- Semiconductor materials revenue growth rate49 %Year on year against the same period last year+49%
- Display materials revenue growth rate-4 %Year on year against the same period last year-4%
- Inorganic colloids revenue growth rate27 %Year on year against the same period last year+27%
- Free cash flow¥151 hundred millionYear on year against the same period last year+¥2.1 billion
- Equity ratio69.8 %
- Net debt-to-equity ratio0.04 times
- Reduce GHG emissionsTarget valueAt least 30% reduction from FY2018Target fiscal yearFY2027
- Percentage of revenue from products and services that contribute to solving social issuesTarget valueAt least 60%Target fiscal year2027
- Positive response rate on talent development in employee engagement surveyTarget value65% or higherTarget fiscal year2027
- Percentage of women in career-track positions at research institutesTarget value18% or moreTarget fiscal year2027
- FY2025 domestic ammonia production capacity share11 %
- Semiconductor materials market growth rate (2024–2030 CAGR)10 %
- Our semiconductor materials revenue growth rate (2024–2030 CAGR)+20%~
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥788 hundred million (YoY +13.0%) |
| Operating profit | ¥219 hundred million (YoY +21.0%) |
| Ordinary income | ¥236 hundred million (YoY +30.0%) |
| Net income | ¥168 hundred million (YoY +21.0%) |
| Operating profit margin | 27.8 % |
| Results for the three months of the current quarter | Net Sales ¥788 hundred million / Operating profit ¥219 hundred million / Ordinary income ¥236 hundred million / Net income ¥168 hundred million / EBITDA ¥255 hundred million / EPS ¥125.74 per share |
| Full-year earnings forecast | Net Sales ¥2,897 hundred million / Operating profit ¥668 hundred million / By segment Functional Materials Net Sales ¥1,261 hundred million / Operating profit ¥386 hundred million / Agricultural Chemicals Net Sales ¥972 hundred million / Operating profit ¥270 hundred million / Chemicals Net Sales ¥414 hundred million / Operating profit ¥13 hundred million / Healthcare Net Sales ¥55 hundred million / Operating profit ¥11 hundred million |
| Segment results | Functional Materials Net Sales ¥326 hundred million (YoY +26.0%) / Operating profit ¥107 hundred million (YoY +30.0%) / Agricultural Chemicals Net Sales ¥266 hundred million (YoY 0.0%) / Operating profit ¥88 hundred million (YoY +2.0%) / Chemicals Net Sales ¥105 hundred million (YoY +13.0%) / Operating profit ¥9 hundred million (YoY +23.0%) / Healthcare Net Sales ¥19 hundred million (YoY +18.0%) / Operating profit ¥7 hundred million (YoY +50.0%) / Wholesale, other and adjustments Net Sales ¥72 hundred million / Operating profit ¥8 hundred million |
| Breakdown of Factors Affecting the Change | Factors Increase in operating income from functional materials / Amount +¥2.5 billion (year on year), Factors Increase in operating income from agricultural chemicals / Amount +¥200 million (year on year), Factors Increase in operating income from chemicals / Amount +¥200 million (year on year), Factors Increase in operating income from healthcare / Amount +¥200 million (year on year), Factors Increase in fixed costs and other expenses for functional materials / Amount ¥1.6 billion (including ¥1.2 billion for semiconductor materials), Factors Lower-than-expected fixed costs and other expenses for functional materials / Amount ¥1 billion (versus forecast; profit-increasing factor) |
| Key KPIs | Indicator name EBITDA / Value ¥255 hundred million / Year on year against the same period last year +¥4.1 billion, Indicator name EPS / Value ¥125.74 per share / Year on year against the same period last year +¥23.54, Indicator name Operating margin / Value 27.8 % / Year on year against the same period last year +1.9 percentage points, Indicator name Semiconductor materials revenue growth rate / Value 49 % / Year on year against the same period last year +49%, Indicator name Display materials revenue growth rate / Value -4 % / Year on year against the same period last year -4%, Indicator name Inorganic colloids revenue growth rate / Value 27 % / Year on year against the same period last year +27%, Indicator name Free cash flow / Value ¥151 hundred million / Year on year against the same period last year +¥2.1 billion, Indicator name Equity ratio / Value 69.8 % / Year on year against the same period last year Not disclosed, Indicator name Net debt-to-equity ratio / Value 0.04 times / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | Item Assumed full-year exchange rate / Value 150 Yen/Dollar, Item Semiconductor materials market growth rate (2024–2030 CAGR) / Value 10 %, Item Our semiconductor materials revenue growth rate (2024–2030 CAGR) / Value +20%~ |
| Medium-term management plan targets | Item Reduce GHG emissions / Target value At least 30% reduction from FY2018 / Target fiscal year FY2027, Item Percentage of revenue from products and services that contribute to solving social issues / Target value At least 60% / Target fiscal year 2027, Item Positive response rate on talent development in employee engagement survey / Target value 65% or higher / Target fiscal year 2027, Item Percentage of women in career-track positions at research institutes / Target value 18% or more / Target fiscal year 2027 |
| Financial targets | Target value Not disclosed / Actual value Equity ratio 69.8% / Net debt-to-equity ratio 0.04 times |
| Acquisition of treasury shares | Amount under the acquisition limit ¥10.5 billion / Number of shares acquired Not disclosed / Period May 2026–March 2027 |
| Capital expenditures | ¥44 100 million (capital expenditures for the quarter, based on cash flow) |
| Market Size / Share | Item FY2025 domestic ammonia production capacity share / Value 11 %, Item Semiconductor materials market growth rate (2024–2030 CAGR) / Value 10 %, Item Our semiconductor materials revenue growth rate (2024–2030 CAGR) / Value +20%~ |
| New initiatives | Measures Partial revision of executive compensation structure / Details Changed to 50% base compensation, 30% performance-linked compensation and 20% stock-based compensation, with stock-based compensation linked to ROE and TSR / Timing April 2026, Measures Zero N2O emissions from nitric acid plants / Planned investment ¥830 million / Variable costs ¥70 million per year |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher revenue from increased operating rates among Asian customers and stronger semiconductor demand in semiconductor materials, higher revenue from Roundup, Althaea, Velder, Glacia and other products in agricultural chemicals, higher revenue from nitric acid products and high-purity sulfuric acid in chemicals, and higher revenue from Healthcare and Finetech in healthcare contributed to the results. The weaker yen also contributed.